Cannabis Strategic Ventures (NUGS)
0.00
USD |
OTCM |
Apr 24, 16:00
Cannabis Strategic Ventures Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2020 | 26.55% |
| March 31, 2020 | -17.20% |
| December 31, 2019 | 32.31% |
| September 30, 2019 | 13.07% |
| June 30, 2019 | -14.32% |
| March 31, 2019 | -3.30% |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 |
| Date | Value |
|---|---|
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| March 31, 2014 | 19.91% |
| December 31, 2013 | 19.92% |
| September 30, 2013 | 19.92% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-17.20%
Minimum
Mar 2020
32.31%
Maximum
Dec 2019
8.08%
Average
13.07%
Median
Sep 2019
Gross Profit Margin (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 48.70% |
| Palatin Technologies Inc | 95.20% |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |